Home to pharma giants Roche and Novartis, the Swiss city along the Rhine River is attracting biotech companies of all sizes that are driving life sciences innovation.
The partnership adds 10 GMP production lines and 350,000 liters of reactor capacity to support clinical- through commercial-scale active pharmaceutical ingredient supply.
